An Open, Phase I Trial to Assess the Pharmacokinetics and Safety and Tolerability of a Single Oral Dose of AZD5672 in Male and Female Patients of Non-Childbearing Potential, with Active Rheumatoid Arthritis
Study identifier:D1710C00008
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
An Open, Phase I Trial to Assess the Pharmacokinetics and Safety and Tolerability of a Single Oral Dose of AZD5672 in Male and Female Patients of Non-Childbearing Potential, with Active Rheumatoid Arthritis
Medical condition
Rheumatoid Arthritis
Phase
Phase 1
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Feb 2007
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
